Trial · NCT05049616
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Stage 2 Hypertension | Hctz/Lisinopril | 8 | Participants | ||
| Number of Participants With Stage 2 Hypertension | Extended release nifedipine | 12 | Participants | ||
| Number of Participants With Severe Postpartum Hypertension | Hctz/Lisinopril | 6 | Participants | ||
| Number of Participants With Severe Postpartum Hypertension | Extended release nifedipine | 5 | Participants | ||
| Number of Participants Who Received Additional Antihypertensive During Admission | Hctz/Lisinopril | 6 | Participants | ||
| Number of Participants Who Received Additional Antihypertensive During Admission | Extended release nifedipine | 5 | Participants | ||
| Postpartum Length of Stay | Hctz/Lisinopril | 4 | Inter-Quartile Range 3 to 5 | days | |
| Postpartum Length of Stay | Extended release nifedipine | 3 | Inter-Quartile Range 3 to 4 | days | |
| Postpartum Readmission | Hctz/Lisinopril | 5 | Participants | ||
| Postpartum Readmission | Extended release nifedipine | 1 | Participants | ||
| Compliance With Medications | Hctz/Lisinopril | 22 | Participants | ||
| Compliance With Medications | Extended release nifedipine | 26 | Participants | ||
| Postpartum Complications- Number of Participants With ICU Admission | Hctz/Lisinopril | 2 | Participants | ||
| Postpartum Complications- Number of Participants With ICU Admission | Extended release nifedipine | 0 | Participants | ||
| Postpartum Complications- Number of Participants With HELLP (Hemolysis, Elevated Liver Enzymes and Low Platelets) Syndrome | Hctz/Lisinopril | 1 | Participants | ||
| Postpartum Complications- Number of Participants With HELLP (Hemolysis, Elevated Liver Enzymes and Low Platelets) Syndrome | Extended release nifedipine | 0 | Participants | ||
| Postpartum Complications- Number of Participants With Eclampsia | Hctz/Lisinopril | 0 | Participants | ||
| Postpartum Complications- Number of Participants With Eclampsia | Extended release nifedipine | 0 | Participants | ||
| Postpartum Complications- Number of Participants With Stroke | Hctz/Lisinopril | 0 | Participants | ||
| Postpartum Complications- Number of Participants With Stroke | Extended release nifedipine | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05049616/results